Reduction of myocardial lipid content assessed by H1 magnetic resonance spectroscopy in dyslipidemic patients after statins

Abstract Background Dyslipidemia is one of the main modifiable risk factors for cardiovascular diseases, which accounts for one third of total deaths worldwide. Statin is considered the cornerstone therapy for treating dyslipidemic patients. H1 Cardiac magnetic resonance spectroscopy (MRS) is a spec...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Eslam Elsayed Mohamed Elmenyawy, Hend Gamal Abu-El Fadl, Hesham Mohammed Fathy Waly, Abdul Razek Abdul Lateef Maaty, Hanaa Mahmoud Mohammad Abdelaziz
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	SpringerOpen 2024-07-01
סדרה:	The Egyptian Journal of Radiology and Nuclear Medicine
נושאים:	MRS Spectroscopy Dyslipidemia Statin
גישה מקוונת:	https://doi.org/10.1186/s43055-024-01302-2
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!